Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...

The filament of matter stretches 50 million light-years, and contains a row of galaxies 5.5 million light-years long that are rotating in sync with the filament. When you purchase through links on our ...

Researchers at Google have developed a new AI paradigm aimed at solving one of the biggest limitations in today’s large language models: their inability to learn or update their knowledge after ...

Defense Secretary Pete Hegseth outlined plans Friday for a sweeping revamp of the military's acquisition systems, which he described as sluggish and mired in bureaucracy. (Julia Demaree Nikhinson/AP) ...

The Landbank Authority's "Save Our Structures" program sells vacant and abandoned properties for $1 to eligible buyers who commit to redevelopment. The program is tailored to prioritize buyers whose ...

PORTSMOUTH, N.H.--(BUSINESS WIRE)-- Albany International Corp. (NYSE: AIN) announced today that it is exploring strategic alternatives for its structures assembly business, including a potential sale ...

Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...